Companies / BOC Sciences / Zolbetuximab
BOC Sciences

Zolbetuximab | BOC Sciences

Zolbetuximab is a monoclonal antibody that targets CLDN18.2, a biomarker of gastric and gastroesophageal junction (GEJ) adenocarcinoma. Zolbetuximab mediates tumor cell death via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.